Dr. Eva Novoa, researcher at CRG and member of the BIST community, has been recognised by the European Molecular Biology Organization‘s (EMBO) Young Investigator Programme. She is one of 26 scientists chosen in this year’s edition, joining a community of more than 700 current and former awardees.
Dr. Novoa is Group Leader in the Epitranscriptomics and RNA dynamics programme at the CRG, areas of biology that deal with how the information inside our cells is managed and used, particularly focusing on RNA, a molecule that plays a crucial role in turning genetic information into actual functioning parts of the cell.
Both of these fields are crucial for understanding the complexity of how our genetic information is not just stored, but also used dynamically in the body, knowledge that has big implications on understanding the evolution and treatment of disease, and understanding how our bodies work at the molecular level.
“I’m honoured to be part of the prestigious EMBO community, which provides invaluable support in the form of funding, mentoring, training and collaborations. In addition, I am very grateful for the fact that EMBO YIP contemplates measures to help researchers like me, who are mothers with young children, to attend to conferences by covering costs of the travel with family,” says Dr. Novoa.
The EMBO Young Investigator Programme is an initiative that supports excellent young group leaders in the early stages of their independent careers. Starting in January 2024, the new EMBO Young Investigators will receive a wide range of financial and practical support. Participants will receive training in leadership skills and responsible research practices, support for lab members, and access to core facilities at the European Molecular Biology Laboratory (EMBL).
Young Investigators also receive an award of 15,000 euros in the second year of their tenure and can apply for additional funding of up to 10,000 euros per year. Travel grants and mentorship opportunities are among many other benefits.